Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T-cells-Reference-Cited by-同舟云学术

Neurologic toxicities following adoptive immunotherapy with BCMA-directed CAR T-cells

Published:2023-07-20 Issue: Volume: Page:
ISSN:0006-4971
Container-title:Blood Journal
language:en
Short-container-title:

Author:

Karschnia Philipp¹^ORCID,Miller Kevin C.²^ORCID,Yee Andrew J.³,Rejeski Kai⁴,Johnson P. Connor Connor⁵^ORCID,Raje Noopur²,Frigault Matthew J²,Dietrich Jorg²

Affiliation:

1. Ludwig-Maximilians-University, Munich, Germany, Germany

2. Massachusetts General Hospital, Boston, Massachusetts, United States

3. Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States

4. University Hospital, LMU Munich, Munich, Germany

5. Massachusetts General Hospital / Harvard Medical School, Boston, Massachusetts, Massachusetts, United States

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

https://ashpublications.org/blood/article-pdf/doi/10.1182/blood.2023020571/2065129/blood.2023020571.pdf

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Timing of Toxicities and Non-Relapse Mortality Following CAR T Therapy in Myeloma;Transplantation and Cellular Therapy;2024-09

2. The first case of multiple myeloma treated with ASCT followed by Anti-BCMA CAR-T cells using retrovirus vector: A case report;Heliyon;2024-09

3. Parkinsonism Following Chimeric Antigen Receptor T Cell Therapy;JAMA Neurology;2024-08-12

4. Comparing the Differences in Adverse Events among Chimeric Antigen Receptor T-Cell Therapies: A Real-World Pharmacovigilance Study;Pharmaceuticals;2024-08-05

5. Bispecific antibodies and autologous chimeric antigen receptor T cell therapies for treatment of hematological malignancies;Molecular Therapy;2024-08